FDA Inspection 1173997 — EirGenix GmbH
The FDA completed an inspection of EirGenix GmbH on Jun 29, 2022 in Munich. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 29, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Munich (Germany)
Additional Details
Sponsor, Contract Research Organization